Paloma Partners’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-358,288
| Closed | -$30.5M | – | 2479 |
|
|
2020
Q3 | $30.5M | Buy |
358,288
+102,587
| +40% | +$5.19M | 0.77% | 10 |
|
|
2020
Q2 | $9.06M | Buy |
+255,701
| New | +$7.48M | 0.16% | 122 |
|
|
2020
Q1 | – | Sell |
-20,129
| Closed | -$426K | – | 2358 |
|
|
2019
Q4 | $426K | Buy |
+20,129
| New | +$355K | 0.01% | 1504 |
|
|
2017
Q2 | – | Sell |
-143,653
| Closed | -$929K | – | 2536 |
|
|
2017
Q1 | $929K | Buy |
143,653
+43,653
| +44% | +$221K | 0.01% | 1275 |
|
|
2016
Q4 | $367K | Buy |
+100,000
| New | +$296K | ﹤0.01% | 1639 |
|
|
2016
Q3 | – | Sell |
-32,086
| Closed | -$74K | – | 2252 |
|
|
2016
Q2 | $74K | Buy |
+32,086
| New | +$107K | ﹤0.01% | 2092 |
|
|
2014
Q4 | – | Sell |
-18,495
| Closed | -$69K | – | 1450 |
|
|
2014
Q3 | $69K | Buy |
+18,495
| New | +$62.5K | ﹤0.01% | 927 |
|
Paloma Partners's IMMU Position: Q4 2020 in Review
Paloma Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 358,288 shares — an estimated $30.5M sold.
Paloma Partners first reported a position in IMMU in Q3 2014 and held it in 7 quarters. The position peaked at $30.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Paloma Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Paloma Partners sold 358,288 Immunomedics Inc shares in Q4 2020, an estimated $30.5M.
- Paloma Partners first reported a position in Immunomedics Inc in Q3 2014 and held it in 7 quarters.
- Paloma Partners's Immunomedics Inc position peaked at $30.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.